All news

All News
  • Legend
  • corporate
  • finance
  • sciences
  • Event

    5th Annual Cancer BioPartnering & Investment Forum

    New York City, USA

    learn more
  • Press release

    PFIC Annual information Statement

    learn more download
  • Press release

    Servier and Pfizer announce FDA clearance of IND application for UCART19 in Adult Relapsed/Refractory Acute Lymphoblastic Leukemia

    9 March 2017 – Servier, together with Pfizer Inc. (NYSE:PFE) and Cellectis (Alternext: ALCLS; Nasdaq: CLLS), announced today that...

    learn more
  • News

    Servier and Pfizer announce FDA clearance of IND application for UCART19 in Adult Relapsed/Refractory Acute Lymphoblastic Leukemia

    read more
  • Press release

    Five Additional Leading Physicians to Join Cellectis Clinical Advisory Board

    New Board Members Include Hematology Experts Catherine Bollard, Hervé Dombret, Ola Landgren, Marcela Maus & Dietger...

    learn more download

Pages